Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Outset Medical Inc (OM)

Outset Medical Inc (OM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire - Wed Feb 11, 3:02PM CST

SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less...

OM : 3.61 (+1.40%)
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned GlobeNewswire - Tue Jan 27, 8:00AM CST

SAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis...

OM : 3.61 (+1.40%)
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 GlobeNewswire - Mon Jan 26, 3:05PM CST

SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity...

OM : 3.61 (+1.40%)
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results GlobeNewswire - Mon Jan 12, 7:30AM CST

SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today...

OM : 3.61 (+1.40%)
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire - Mon Jan 5, 3:05PM CST

SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity...

OM : 3.61 (+1.40%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM PR Newswire - Thu Jan 1, 9:00AM CST

NEW YORK , Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM). Such investors are...

OM : 3.61 (+1.40%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM PR Newswire - Thu Dec 11, 2025

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM). Such investors are...

OM : 3.61 (+1.40%)
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Outset Medical, Inc. (NASDAQ: OM) and Encourages Investors with Substantial Losses to Contact the Firm PR Newswire - Fri Nov 28, 2025

NEWTOWN, Pa. , Nov. 28, 2025 /PRNewswire/ --  Edelson Lechtzin LLP  is investigating potential violations of the federal securities laws involving Outset Medical, Inc. (NASDAQ: OM), resulting...

OM : 3.61 (+1.40%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM PR Newswire - Thu Nov 20, 2025

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM). Such investors are...

OM : 3.61 (+1.40%)
Outset Medical Reports Third-Quarter Results GlobeNewswire - Mon Nov 10, 2025

SAN JOSE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis,...

OM : 3.61 (+1.40%)

Barchart Exclusives

2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now Barchart - 1 hour ago
2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.